Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Holding TERN?
Track your performance easily

Terns Pharmaceuticals (TERN) Financial Statements

222 Followers

Terns Pharmaceuticals Financial Overview

Terns Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.312; its P/E ratio is -6.82; Terns Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -25.54M$ -25.45M$ -33.18M$ -17.82M$ -21.47M
EBITDA$ -25.30M$ -25.21M$ -32.96M$ -18.58M$ -22.05M
Net Income Common Stockholders$ -22.74M$ -22.37M$ -29.77M$ -17.90M$ -21.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 225.30M$ 240.65M$ 266.60M$ 285.60M$ 297.53M
Total Assets$ 230.88M$ 246.77M$ 271.69M$ 289.70M$ 300.60M
Total Debt$ 249.00K$ 427.00K$ 770.00K$ 876.00K$ 1.04M
Net Debt$ -225.05M$ -240.23M$ -265.83M$ -284.73M$ -296.48M
Total Liabilities$ 12.20M$ 10.05M$ 13.26M$ 15.55M$ 13.60M
Stockholders Equity$ 218.68M$ 236.72M$ 258.43M$ 274.15M$ 287.68M
Cash Flow-
Free Cash Flow$ -16.19M$ -22.83M$ -20.71M$ -12.99M$ -14.38M
Operating Cash Flow$ -16.18M$ -22.80M$ -20.70M$ -12.99M$ -14.38M
Investing Cash Flow$ 42.19M$ 8.00M$ -22.31M$ -90.84M$ 27.93M
Financing Cash Flow$ 399.00K-$ 20.00K$ 489.00K$ 27.58M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

Terns Pharmaceuticals Debt to Assets

Terns Pharmaceuticals Cash Flow

Terns Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis